Although EGFR inhibitors improve patient survival, they are also associated with skin toxicity, including acneiform rash, xerosis, paronychia, and pruritus, and hair, eyelash, and mucosal changes [8–10]. The gene discussed is EGFR; the disease is acneiform dermatitis.